ShlA toxin of Serratia induces P2Y2- and α5β1-dependent autophagy and bacterial clearance from host cells

[1]  G. Weisman,et al.  Therapeutic potential for P2Y2 receptor antagonism , 2022, Purinergic Signalling.

[2]  Fatima R. Ulhuq,et al.  Bacterial pore-forming toxins , 2022, Microbiology.

[3]  D. Kofteridis,et al.  Infective endocarditis by Serratia species: a systematic review , 2022, Journal of chemotherapy.

[4]  M. Bartlam,et al.  Structural characterization of the urease accessory protein UreF from Klebsiella pneumoniae. , 2022, Acta crystallographica. Section F, Structural biology communications.

[5]  K. Alleva,et al.  Interactive Dynamics of Cell Volume and Cell Death in Human Erythrocytes Exposed to α-Hemolysin from Escherichia coli , 2022, International journal of molecular sciences.

[6]  S. Macdonald,et al.  Emerging therapeutic opportunities for integrin inhibitors , 2021, Nature reviews. Drug discovery.

[7]  G. Perkins,et al.  Structure versus function: Are new conformations of pannexin 1 yet to be resolved? , 2021, The Journal of general physiology.

[8]  J. Chander,et al.  Serratia no longer an opportunistic uncommon pathogen - case series & review of literature. , 2021, Infectious disorders drug targets.

[9]  J. Camden,et al.  P2Y Receptors for Extracellular Nucleotides: Contributions to Cancer Progression and Therapeutic Implications. , 2021, Biochemical pharmacology.

[10]  H. Zimmermann.  Ectonucleoside triphosphate diphosphohydrolases and ecto-5′-nucleotidase in purinergic signaling: how the field developed and where we are now , 2020, Purinergic Signalling.

[11]  G. Beldi,et al.  Extracellular ATP as an Inter-Kingdom Signaling Molecule: Release Mechanisms by Bacteria and Its Implication on the Host , 2020, International journal of molecular sciences.

[12]  Xuekui Yu,et al.  Cryo-EM structure of human heptameric Pannexin 1 channel , 2020, Cell Research.

[13]  F. Di Virgilio,et al.  Purinergic signalling, DAMPs and inflammation. , 2020, American journal of physiology. Cell physiology.

[14]  I. Kügelgen.  Pharmacology of P2Y receptors , 2019, Brain Research Bulletin.

[15]  C. Kennedy,et al.  Characterisation of P2Y2 receptors in human vascular endothelial cells using AR‐C118925XX, a competitive and selective P2Y2 antagonist , 2019, British journal of pharmacology.

[16]  V. Herlax,et al.  Regulation of extracellular ATP of human erythrocytes treated with α-hemolysin. Effects of cell volume, morphology, rheology and hemolysis. , 2019, Biochimica et biophysica acta. Molecular cell research.

[17]  M. L. Cristina,et al.  Serratia marcescens Infections in Neonatal Intensive Care Units (NICUs) , 2019, International journal of environmental research and public health.

[18]  G. Burnstock.  Purine and purinergic receptors , 2018, Brain and neuroscience advances.

[19]  F. Di Virgilio,et al.  Extracellular nucleotides and nucleosides as signalling molecules. , 2018, Immunology letters.

[20]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[21]  Zuocheng Yang,et al.  The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells , 2017, International journal of molecular medicine.

[22]  C. Müller,et al.  Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925 , 2017, Purinergic Signalling.

[23]  E. García Véscovi,et al.  A pore‐forming toxin enables Serratia a nonlytic egress from host cells , 2017, Cellular microbiology.

[24]  P. Schwarzbaum,et al.  Dynamic Regulation of Cell Volume and Extracellular ATP of Human Erythrocytes , 2016, PloS one.

[25]  C. Orihuela,et al.  Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia , 2015, PLoS pathogens.

[26]  G. Dahl.  ATP release through pannexon channels , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[27]  C. Orihuela,et al.  Requirement for Serratia marcescens Cytolysin in a Murine Model of Hemorrhagic Pneumonia , 2014, Infection and Immunity.

[28]  M. Ombok,et al.  Serratia marcescens is injurious to intestinal epithelial cells , 2014, Gut microbes.

[29]  S. Orlov,et al.  Hemolysis is a primary ATP-release mechanism in human erythrocytes. , 2014, Blood.

[30]  E. García Véscovi,et al.  Serratia marcescens ShlA Pore-Forming Toxin Is Responsible for Early Induction of Autophagy in Host Cells and Is Transcriptionally Regulated by RcsB , 2014, Infection and Immunity.

[31]  Roberto L. Mempin,et al.  Release of extracellular ATP by bacteria during growth , 2013, BMC Microbiology.

[32]  O. Pignataro,et al.  Kinetics of extracellular ATP in mastoparan 7-activated human erythrocytes. , 2013, Biochimica et biophysica acta.

[33]  Chien-Chang Yang,et al.  Serratia marcescens meningitis: epidemiology, prognostic factors and treatment outcomes. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[34]  H. Kessler,et al.  Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: a method to discriminate integrin subtypes in vitro. , 2013, Angewandte Chemie.

[35]  A. Chattopadhyay,et al.  Comparative Analysis of Calcium Spikes upon Activation of Serotonin1A and Purinergic Receptors , 2012, PloS one.

[36]  T. Vorup-Jensen,et al.  Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor‐dependent lysis of human erythrocytes , 2012, Cellular microbiology.

[37]  K. Janda,et al.  Modulation of translation and induction of autophagy by bacterial exoproducts , 2012, Medical Microbiology and Immunology.

[38]  Steven D. Mahlen.  Serratia Infections: from Military Experiments to Current Practice , 2011, Clinical Microbiology Reviews.

[39]  E. García Véscovi,et al.  Serratia marcescens Is Able to Survive and Proliferate in Autophagic-Like Vacuoles inside Non-Phagocytic Cells , 2011, PloS one.

[40]  U. Jensen,et al.  Escherichia coli α-Hemolysin Triggers Shrinkage of Erythrocytes via KCa3.1 and TMEM16A Channels with Subsequent Phosphatidylserine Exposure* , 2010, The Journal of Biological Chemistry.

[41]  D. Spray,et al.  Mefloquine Blockade of Pannexin1 Currents: Resolution of a Conflict , 2010, Cell communication & adhesion.

[42]  A. Dessì,et al.  Serratia marcescens Infections and Outbreaks in Neonatal Intensive Care Units , 2009, Journal of chemotherapy.

[43]  N. Jørgensen,et al.  α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis , 2009, Proceedings of the National Academy of Sciences.

[44]  G. Dahl,et al.  A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. , 2009, American journal of physiology. Cell physiology.

[45]  Y. Shirai,et al.  Ca2+ oscillation induced by P2Y2 receptor activation and its regulation by a neuron-specific subtype of PKC (γPKC) , 2008, Neuroscience Letters.

[46]  M. Colombo,et al.  Autophagy: for better or for worse, in good times or in bad times. , 2008, Current molecular medicine.

[47]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[48]  M. Skalski,et al.  SNARE-mediated trafficking of α5β1 integrin is required for spreading in CHO cells , 2005 .

[49]  G. Burnstock,et al.  P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[50]  Heinz Schwarz,et al.  Serratia marcescens internalization and replication in human bladder epithelial cells , 2004, BMC infectious diseases.

[51]  B. Finlay,et al.  Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening , 2003, The EMBO journal.

[52]  X. Pillois,et al.  Nucleotide Receptors Involved in UTP-Induced Rat Arterial Smooth Muscle Cell Migration , 2002, Circulation research.

[53]  R. Hertle.  Serratia type pore forming toxins. , 2000, Current protein & peptide science.

[54]  I. Walev,et al.  Cytotoxic Action of Serratia marcescens Hemolysin on Human Epithelial Cells , 1999, Infection and Immunity.

[55]  T. K. Harden,et al.  Agonist action of adenosine triphosphates at the human P2Y1 receptor. , 1998, Molecular pharmacology.

[56]  H. Ni,et al.  Integrin Activation by Dithiothreitol or Mn2+ Induces a Ligand-occupied Conformation and Exposure of a Novel NH2-terminal Regulatory Site on the β1Integrin Chain* , 1998, The Journal of Biological Chemistry.

[57]  P. Goluszko,et al.  Extracellular haemolytic activity of Serratia marcescens. , 1989, FEMS microbiology letters.

[58]  V. Braun,et al.  Subcellular location and unique secretion of the hemolysin of Serratia marcescens. , 1989, The Journal of biological chemistry.

[59]  V. Braun,et al.  Molecular characterization of the hemolysin determinant of Serratia marcescens , 1988, Journal of bacteriology.

[60]  V. Braun,et al.  Identification of the Serratia marcescens hemolysin determinant by cloning into Escherichia coli , 1987, Journal of bacteriology.

[61]  P. A. Lanzetta,et al.  An improved assay for nanomole amounts of inorganic phosphate. , 1979, Analytical biochemistry.

[62]  Geoffrey Burnstock,et al.  Introductory overview of purinergic signalling. , 2011, Frontiers in bioscience.

[63]  J. M. Alés Reinleìn,et al.  [Serratia marcescens]. , 1971, Revista clinica espanola.